Trade-Ideas LLC identified Celldex Therapeutics Inc. (NASDAQ:CLDX) as a “dead cat bounce” candidate. TheStreet Quant Ratings rates Celldex Therapeutics Inc. (NASDAQ:CLDX) as a sell. Celldex Therapeutics, Inc. (NASDAQ:CLDX) net profit margin is % and weekly performance is %. On last trading day company shares ended up $12.79. Analysts mean target price for the company is $36.00. Celldex Therapeutics, Inc. (NASDAQ:CLDX) distance from 50-day simple moving average (SMA50) is -32.29%.
Brean Capital decreased their price target on shares of Baxano Surgical Inc (NASDAQ:BAXS) from $4.00 to $3.50 in a research note issued on Friday, Stock Ratings Network reports. Brean Capital’s price objective would suggest a potential upside of 337.50% from the company’s current price. Baxano Surgical Inc (NASDAQ:BAXS) shares fell -14.13% in last trading session and ended the day on $0.687. BAXS Gross Margin is 69.90% and its return on assets is -69.20%. Baxano Surgical Inc (NASDAQ:BAXS) quarterly performance is -47.33%.
American Superconductor Corporation (NASDAQ:AMSC) has entered a Cooperative Research and Development Agreement (CRADA) with the US Department of Energy’s (DoE) National Renewable Energy Laboratory (NREL) and its National Wind Technology Center (NWTC) to validate the economics of a full 10 MW class superconductor wind turbines under development by American Superconductor Corporation (NASDAQ:AMSC). American Superconductor Corporation (NASDAQ:AMSC) shares moved up 1.59% in last trading session and was closed at $1.28, while trading in range of $1.25 – $1.30. American Superconductor Corporation (NASDAQ:AMSC) year to date (YTD) performance is -21.95%.
Arctic Cat Inc. (NASDAQ:ACAT), reported net earnings of $12.1 million, or $0.89 per diluted share, for the fiscal third quarter ended December 31, 2013, compared to prior-year record net earnings of $17.9 million, or $1.30 per diluted share. Net sales in the third quarter were $225.8 million, up from net sales of $218.0 million in the same quarter last year. Arctic Cat Inc (NASDAQ:ACAT) ended the last trading day at $38.60. Company weekly volatility is calculated as 3.09% and price to cash ratio as 8.12. Arctic Cat Inc (NASDAQ:ACAT) showed a negative weekly performance of -7.08%.
Leave a Reply